Previous clinical studies have demonstrated thatelevated HMGB2 expression correlates with the severity of myocardial infarction(MI), major adverse cardiovascular events (MACEs) at one month, and in-stentrestenosis [18, 19]. This evidence concerns the gene HMGB2 and myocardial infarction.